Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer
- 1 January 2006
- journal article
- lung cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (1), 59-63
- https://doi.org/10.1200/jco.2005.02.9827
Abstract
Purpose Lung cancer is the leading cause of cancer-related death in women. Hormone replacement therapy (HRT) is frequently prescribed to postmenopausal women, but there is little data on its effect on lung cancer. Hence, we conducted a retrospective study to examine the impact of HRT on the natural history of lung cancer. Methods We conducted a retrospective chart review of women diagnosed with lung cancer between January 1994 and December 1999. Data collected included age, stage, past history of cancer, smoking history, family history of cancer, HRT use, treatment, and overall survival. The effects of various clinical features on survival were examined using Cox proportional hazards regression models. Results Four hundred ninety-eight women (median age, 67 years; range, 31 to 93 years) with lung cancer were included. A history of smoking was present in 429 women (86%), whereas 86 women (17%) had taken HRT. Women with lung cancer who received HRT were younger than women with lung cancer who never received HRT (63 v 68 years old, respectively; P < .0001). Overall survival was significantly higher in patients with no HRT compared with patients who received HRT (79 v 39 months, respectively; hazard ratio = 1.97; 95% CI, 1.14 to 3.39). This effect seemed to be more pronounced in women with a smoking history. Conclusion HRT may affect outcomes from lung cancer adversely. Further studies examining the role of HRT use on outcomes from lung cancer, especially in women with a history of smoking, are urgently needed to clarify this important problem.Keywords
This publication has 20 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Lung Cancer Rates in Men and Women With Comparable Histories of SmokingJNCI Journal of the National Cancer Institute, 2004
- Gender and Lung CancerClinical Lung Cancer, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- Hormonal factors and risk of lung cancer among women?International Journal of Epidemiology, 2003
- Estrogen replacement therapy and risk of lung cancerPharmacoepidemiology and Drug Safety, 2002
- Expression of estrogen receptors α and β in human lung tissue and cell linesLung Cancer, 2002
- Re: Endocrine Factors and Adenocarcinoma of the Lung in WomenJNCI Journal of the National Cancer Institute, 1994
- Race and Sex Differences in Lung Cancer Risk Associated with Cigarette SmokingInternational Journal of Epidemiology, 1993
- Risk of cancer in women receiving hormone replacement therapyInternational Journal of Cancer, 1989